Antibiotic resistance consists of a dynamic web. In this review, we describe the path by which different antibiotic residues and antibiotic resistance genes disseminate among relevant reservoirs (human, animal, and environmental settings), evaluating how these events contribute to the current scenario of antibiotic resistance. The relationship between the spread of resistance and the contribution of different genetic elements and events is revisited, exploring examples of the processes by which successful mobile resistance genes spread across different niches. The importance of classic and next generation molecular approaches, as well as action plans and policies which might aid in the fight against antibiotic resistance, are also reviewed.
Introduction
Many classes of antibiotics are not only clinically valuable in human medicine, but also in other fields such as veterinary medicine and animal food production, including aquaculture [1, 2] . The agricultural setting also plays an important role in the spread of antibiotic residues in the environment due to their use as additives and biocides in crops. Consequently, all adjacent natural environments consisting of water, soil and plants are environmental niches to be taken into consideration in the dynamics of antimicrobial resistance [3, 4] .
The use of antibiotics may have dangerous long-term effects that extend beyond selection of specific resistance mechanisms [5] . The selection pressure applied to bacterial communities via widespread discharge of antibiotic residues in the environment strongly contributes to the exposure of several niches to antibiotic-resistant bacteria (commensal and/or pathogenic) [6] . For example, use of animal manure may enhance viable antibiotic-resistant coliform bacteria in soil, increasing the frequency of detection of some antibiotic resistance genes [3] . These bacteria may reach the food chain, since vegetables are grown in soil [7] . Acquired antibiotic resistance is also frequent among isolates from wild animals which represents a niche of concern. Indeed, many reports point to wild animals as reservoirs of resistant determinants that commonly appear in other habitats, namely in human settings [8] .
It should also be noted that bacterial resistance to antibiotics is related to soil and aquatic native microorganisms which may be producers of antimicrobial compounds [9, 10] . Several other factors contribute to antibiotic resistance. Indeed, the existence of major anthropogenic actions such as international travel and global trade in foodstuffs strongly contribute to its amplification [11e14] (Table 1) . A classical example of a vehicle for transmission of antibiotic-resistant bacteria is the human hand, which can become easily contaminated by environmental surfaces near patients in hospitals or animals in husbandry settings [15, 16] . Consequently, the World Health Organization is strongly committed to making people aware of the problem of antibiotic resistance, and especially caretakers, namely through promoting hand hygiene for fighting antibiotic resistance [16, 17] .
There exists an urgent need to elucidate possible connections between antibiotics, environmental organisms and associated bacterial communities, as they may threaten diverse ecosystems and consequently human health [18] . In this review, we emphasize that these settings are linked and may constitute reservoirs of antibiotic resistance determinants, playing important roles in their dynamics.
Antibiotic residues versus resistomes in the environment
Before the antibiotic era, environmental antibiotic-resistant bacteria already existed, carrying genes that became critically important in medicine [19] . Indeed, for many years the environment consisted of an under-recognized reservoir of resistance genes that have the potential to be transferred and emerge in clinically important bacteria [20e22]. Groh et al. (2006) showed that homologues of multidrug resistance genes present in bacterial pathogens are essential for sediment fitness in non-pathogenic bacteria, by conferring an ecological advantage on these microorganisms [23] .
Several reports have demonstrated the existence of antibacterial activity in extracts from different microorganism genera/species against distinct bacteria. A recent study showed that some antibiotic-resistant Gram-negative strains recovered from an industrial alpine location highly polluted with oil hydrocarbons had the ability to produce antimicrobial compounds active against Actinobacteria and Gammaproteobacteria. Thus, the selection pressure present in this environment could lead not only to high antibiotic resistance, but also to the capacity of this population to produce antimicrobial compounds [24] . LeBel et al. (2013) also demonstrated that the heat-stable bacteriocin nisin (naturally produced by Lactococcus lactis) displayed antimicrobial activity against the emerging zoonotic agent Streptococcus suis [25] .
In fact, several studies have demonstrated that freshwater/ marine bacteria are also able to produce antibacterial compounds that exhibit antimicrobial activity similar to standard drugs, which is the case for cyanobacteria [26] . In addition, it was demonstrated that extracts from Anabaena spp. were effective against vancomycin-resistant Staphylococcus aureus [27] . Some authors consider that cyanobacteria antibacterial activity is more effective against Gram-positive bacteria [28, 29] than Gram-negative, attributed to the protection conferred by the lipopolysaccharide barrier of the Gramnegative cell wall [28] ; however, some Gram-negative bacteria, including pathogenic species, are also affected by cyanobacterial compounds. The potential application of bacterial compounds to the development of new antimicrobials therefore appears to be a promising research area.
The relationship between bacteria and antibiotics may be approached in a variety of ways. In the case of cyanobacteria, considering their ubiquity and importance in the ecosystems [30] , increasing concern has been attributed to the effects of environmental stressors in these bacteria. In fact, although cyanobacteria can easily adapt to different environmental conditions, they can also be severely affected by Table 1 Antibiotic resistance is generated by several factors (adapted from [11e13]).
Factors depending on biological and physical influences:
Human environmental changes and water contaminants [31, 32] . On the other hand, and given that cyanobacteria are exposed to antibiotics and resistant bacteria in their natural habitats [18] , we hypothesize that they are able to develop antibiotic resistance mechanisms. Their ability to produce a variety of bioactive antibacterial compounds with potential pharmaceutical interest [26] suggests that they may have developed defense mechanisms against their own toxicity [33] . The role of antibacterial-compound-producing bacteria is a challenge to the scientific community, since these new molecules may constitute a promising future source of antimicrobials. Thus, further research will be needed to understand the effect of such genera/species on the resistome.
The mobilome associated with antibiotic resistance genes
Genomic events constitute a central process in the mobilization of genetic elements and associated mobile antibioticresistance-encoding genes in different settings [34] . The movement of bacteria from the environment to animals and humans (and vice-versa) contributes to an increase in the mobilome (mobile gene pool) [35] . These genetic exchanges have been significantly reported among human and animal guts [36] . Indeed, lateral gene transfer and recombination of genetic material within bacterial populations strongly contributes to the diversity and adaptability of strains to different environments (Fig. 1) .
The wide divergence within specific functional genes, the creation of mosaic-structured genomic regions, as well as the high prevalence of mobile genetic elements contribute to the success of different gene pools, producing new worldwide dispersed hotspots [5, 14, 20, 34] . For instance, the acquisition of a single plasmidic but pleiotropic gene that encodes resistance to two structurally and functionally different classes of antibiotics also highlights the remarkable adaptive nature of Gram-negative bacteria [37] .
In general, mobile genetic elements such as plasmids, insertion sequences (ISs), transposons, genomic islands and phages, constitute the arsenal of bacterial genomes in terms of genetic transfer, contributing to the emergence of novel genotypic and phenotypic variants [35, 38, 39] . Frequently, these genetic structures may be organized in cascade-like arrangements, contributing to the amplification of mobilization events.
Several reports revealed that mutations in the promoter region and acquisition of functional promoters can turn on a silent gene [40] . For example, IS may disrupt open reading frames and activate gene expression through transposition. A functional promoter may be created through the À35 promoter-like sequence existing in the terminal of some IS elements [40] .
The mobilome and the resistome usually follow parallel paths. The environment is broadening the origin of antibiotic resistance genes. This was the case for Kluyvera spp., commensal bacteria of both humans and animals, which went ahead to the mobilization of their chromosomal CTX-M-type b-lactamase-encoding genes into the plasmids of other bacteria. Thus, CTX-M extended-spectrum b-lactamase (ESBL) has its origin in Kluyvera spp., which possibly shares other genes with enteric bacteria [41] . The understanding that genes from non-related species might be expressed in new hosts is now evident [6, 8, 9] . Another example is OXA-type-b-lactamases. Interestingly, the genes encoding these enzymes have already been described in plasmids prior to the human use of antibiotics, since they have moved through horizontal gene transfer between bacterial phyla for millions of years [42] . Recently, an OXA carbapenemase (from Ambler class D) that supposedly had its origin in Turkey (OXA-48) has been described in Europe and in the USA among Klebsiella pneumoniae isolates, causing considerable morbidity and mortality [43, 44] . The first report of Shewanella xiamenensis carrying a bla OXA-48-like gene suggested that the emergence of different genes from this group had their origin in different S. xiamenensis strains [45] . The contribution of different mobile genetic elements and mechanisms to the dissemination of these carbapenemase-encoding genes (bla OXA-48-like ), from Shewanella spp. to Enterobacteriaceae and to other Gram-negative bacteria, has been reported [46] . These antibiotic resistance genes constitute one of the greatest threats in terms of public health because of their ability to resist carbapenems [43, 47] .
The idea that some resistance mechanisms, such as carbapenemase production, are only linked to infections and human healthcare facilities is no longer valid [48] . The efficacy of bla OXA-48-like gene transfer between bacterial species in human cases [44] has also been reported in food-producing, companion and wild animals, as well as in natural environments [45, 49, 50] , highlighting its importance in the dissemination of antibiotic resistance among different reservoirs.
International travel and medical tourism have rapidly driven the resistance mechanisms into an alarming public health problem [51, 52] . Apart from the enzymes belonging to Ambler class D, this is also happening with other carbapenemases, such 
Investigating antibiotic resistance
Routine investigation of the most relevant antibiotic resistance mechanisms (such as ESBLs, carbapenemases, methicillin-resistant S. aureus/MRSA and vancomycinresistant enterococci/VRE) is becoming common in the human sector; however, it is still scarce in the area of food, animals and the environment. The specific detection of ESBLand carbapenemase-producing bacteria in the environment, on farms, in food and companion animals urgently requires means to contain these resistance mechanisms. This is a matter of concern, as carbapenems are currently one of the last resources for treat complicated human infections caused by multidrug resistant Gram-negative bacteria [48] .
The colonization of healthy animals may represent a silent source of these resistance mechanisms and a possible transmission pathway to humans via the food chain. On the other hand, the carriage of such resistance mechanisms by healthy humans may also cause their transmission to non-human sources. Moreover, infection and colonization are higher among animal owners, farmers and veterinarians. They can be carriers and transmit bacterial antibiotic resistance genes to animals, namely due to prior selection pressure caused by hospitalization, antibiotic consumption, contact with healthcare settings and/or international voyages (Fig. 1) [49] .
Data collection and analysis of antibiotic resistance will improve detection of outbreaks (at a micro-level) and support decision-making (at a macro-level), highlighting the importance of the One-Health approach to combat its global rise in human infectious diseases [17, 53] .
Our capacity to contain the increase and dissemination of resistance mechanisms such as carbapenemase-producing bacteria will eventually indicate the efficiency of antibiotic use and antibiotic resistance containment policies [17, 49] . In 2006, the European Union prohibited antibiotics as growth promoters in animal feed, which was an important step in the use of antibiotics for non-medical purposes. However, the antibiotic resistance of foodborne pathogens remains a matter of concern. The notification rates of zoonoses in confirmed human cases in the EU for the year of 2013 showed that Campylobacter, Salmonella and Escherichia coli were the most frequent bacteria causing human foodborne zoonoses. Despite all efforts, these pathogens still present high levels of resistance to antibiotics used in humans [54] . About 30% of human Salmonella spp. isolates exhibited multidrug resistance [54] .
Emerging antibiotic-resistant foodborne pathogens of animal origin are forcing food and veterinary microbiology laboratories to be increasingly alert due to the impact of these bacteria can on public health. Next-generation sequencing technologies have greatly accelerated the rate and reduced the cost of genomic data acquisition. Whole-genome sequencing (WGS) and molecular epidemiology studies constitute important assets for exploring the bacterial genomes [22, 39, 55] . The possibility of performing comparative genomic analysis in short periods of time can enable rapid detection of resistance genes that, in turn, may be helpful for distinguishing different bacterial subpopulations [22, 55, 56] .
These methodologies are very useful for monitoring the mobilome, as mobile antibiotic resistance genes are frequently clustered in complex genetic arrays. For instance, hitchhiking genes, such as antibiotic resistance and heavy metal or disinfectant resistance genes, are commonly genetically associated. Moreover, there exist genomic regions that enable the gathering of antibiotic resistance genes, such as integrons and those responsible for their transfer, like plasmids and conjugative transposons [40] . Plasmidome sequencing is also an interesting approach for evaluating antibiotic resistance genes that may spread among different settings [35] . Likewise, a complete proteome might be obtained through matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF MS). Correia et al. (2014) reported confirmation of several proteins in S. Typhimurium phage type 104 clinical strain through this method, emphasizing the presence of the Aac(6 0 )-Ib-cr enzyme responsible for both plasmid-mediated aminoglycoside and quinolone resistance [37, 57] .
Likewise, high-throughput sequencing of nine genomes was used for rapid identification of data in an outbreak caused by enteroaggregative verocytotoxin-producing E. coli O104:H4 (STEC) associated with consumption of raw vegetables [55, 58] . This outbreak was responsible for a hemolytic uremic syndrome in patients, due to TEM-and CTX-M-15-producing STEC isolates. The exposure path involved in this outbreak may have been more than one [55, 58] : initially, a primary human infection might have arisen from consumption of contaminated food or direct contact with an animal carrying STEC strains; next, subsequent infection might have occurred by the fecal-oral pathway, through manipulation of contaminated vegetables [55, 58] .
Using the WGS approach, two independent human farm cases of mecC-MRSA infection directly linked to a livestock (cows and sheep) reservoir, were identified in Denmark, supporting zoonotic spread. In these cases, it was demonstrated that the CC130 MRSA lineage was transmitted between animals and humans and that livestock may be a reservoir for MRSA [56] .
Thus, new-generation approaches enable a better understanding of specific resistance mechanisms, permitting effective control of complex epidemiological situations. Overall, the use of many types of "omic" approaches is already providing more advanced hypotheses, mechanisms and models of antibiotic resistance evolution [59] .
Strengthening the combat against antibiotic resistance
Actions should be taken to diminish the selection pressure imposed by antibiotics in human communities. Other priority actions should include risk management to minimize antibiotics and antibiotic-resistant bacteria in animals (companion and food-producing) and in the environment, namely in fresh and wastewater.
Several measures are necessary to fight antibiotic-resistant bacteria, but the main concern involves putting them into practice in all countries, regions and settings [17, 53, 54, 60, 61] .
Council Recommendation/2002/77/EC on the prudent use of antimicrobial agents in human medicine highlights the need for a "relationship between the occurrence of antimicrobial resistance in certain human pathogens and their occurrence in animals and the environment" [60] . In addition, we must be aware of the fact that "coordination between human, veterinary and environment sectors should be ensured and the magnitude of the relationship between the occurrence of antimicrobial resistant pathogens in humans, animals and the environment should be further clarified and therefore this recommendation does not preclude further initiatives in other areas." [60] . Recommendations from other entities reinforce the need to fight against the rising threats of antibiotic resistance, through publication of detailed action plans and ideas underlining important pressure points [17, 62] . We also point out that the Transatlantic Task Force on Antimicrobial Resistance of 2014 issued recommendations for future collaboration between the USA and the EU. In this document, strategies for improving the pipeline of new antibacterial drugs was emphasized [63] . The absence of new antibiotics is the major drawback in the field of antibiotic resistance [64] .
The implementation of DC 613/2013 by EU countries concerning antimicrobial resistance monitoring in zoonotic and commensal agents in 2014 in food-producing animals and meat for a period of seven years (2014e2020), using standardized validated antimicrobial susceptibility testing methods and harmonized interpretive criteria, will complement and provide early warning of changes in resistance patterns in animal populations, and will monitor future trends in the occurrence of antimicrobial resistance [65] .
Many European programs have also been developing policies for diminishing antibiotic use and antibiotic resistance genes in different sources, namely water [66] . In water, reservoirs are highlighted by the recent COST action that takes into account the problem of antibiotics and their consequences, the main objective of which is to make possible wastewater reuse [http://www.nereus-cost.eu/].
Meanwhile, national strategies for combatting antibioticresistant bacteria, identifying priorities and coordinating investments were recently reviewed in the USA [67] . The evaluation of antibacterial products used as feed additives and the impact of antimicrobial resistance on antibiotics of human and veterinary importance have also been revised [68] .
Conclusions
Antibiotic resistance constitutes a health crisis that has consequences throughout the world, striking several settings simultaneously: humans, animals and natural environments. Until the decade of the 90's, the majority of drugs, including antibiotics, were derived from natural products; since then, a substantial increase in the use of synthetic and semi-synthetic substances as therapeutic agents has occurred [69] . However, the major approach of the pharmaceutical industry to overcoming this problem was an improvement in pre-existing antibiotics to the detriment of research on new molecules [69] . In the future, special attention should be paid to the potential of new natural antimicrobial products as effective and less toxic alternatives [70] .
Overall, actions must be taken to diminish selection pressures imposed by antibiotics, in order to reduce exposure of humans to high rates of antibiotic-resistant strains. Priority actions include risk management to access the use of antibiotics and the presence of resistant bacteria in the different environments. In the end, a higher economic and human investment in the field is necessary.
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